SLC2A1 and acute lymphoblastic leukemia: SLC2A1 expression is negatively correlated with CD8+ T cells in 12 types of cancers (LUSC, TGCT, THYM, HNSC, BRCA, SKCM, STES, GBMLGG, GBM, PAAD, ALL, and ESCA), but positively correlated with CD8+ T cells in 5 types of cancers (KIPAN, LIHC, LAML, PCPG, and CHOL) (Figure 13B).